Patents Assigned to SLH Innovations LLC
  • Methods for treating cancer
    Patent number: 10889619
    Abstract: The invention relates to novel peptides having an HDM-2 targeting sequence that target the human minute binding protein-2. The invention also relates to fusion proteins comprising a HDM-2 targeting sequence. The invention also relates to methods of using the peptides to treat cancer.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: January 12, 2021
    Assignee: SLH Innovations LLC
    Inventor: Matthew R. Pincus
  • Methods for treating cancer
    Patent number: 10759832
    Abstract: Peptides having a human minute binding protein-2 (HDM-2) targeting sequence that target the human minute binding protein-2, fusion proteins having a HDM-2 targeting sequence, and methods of using the peptides and proteins to treat cancer are described.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: September 1, 2020
    Assignee: SLH Innovations LLC
    Inventor: Matthew R. Pincus
  • Methods for treating cancer
    Patent number: 10400012
    Abstract: Peptides having a human minute binding protein-2 (HDM-2) targeting sequence are capable of targeting the human minute binding protein-2. Peptides having an HDM-2 targeting sequence may be used to treat cancer.
    Type: Grant
    Filed: September 18, 2017
    Date of Patent: September 3, 2019
    Assignee: SLH Innovations LLC
    Inventor: Matthew R. Pincus